Morgan Ebert, Managing Editor

A study finds that esketamine during cesarean delivery may reduce postpartum depression risk, though further research is needed to confirm its safety and efficacy.

A survey by Aeroflow Urology finds many mothers face postpartum incontinence without medical support, impacting their health, stress, and daily life.

BlueWind Medical’s Revi System shows strong two-year efficacy and safety for UUI, with symptom reduction and high patient satisfaction.

Nicola F. Tavella, MPH, dives into his team's research on postpartum depression and unplanned cesarean delivery, which was presented at SMFM's 2025 Pregnancy Meeting.

A new study links first-trimester hemorrhage and anemia to a higher placenta accreta spectrum risk, emphasizing early screening and non-traditional risk factors.

AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.

Researchers have identified higher concentrations of microplastics and nanoplastics in the placentae of infants born prematurely compared to those born at term, a new study finds.

A new study presented at the SMFM 2025 Pregnancy Meeting found that homicide and suicide are the leading causes of maternal death in the United States.

Gameto’s Fertilo gets FDA clearance for a phase 3 trial, pioneering iPSC-based fertility treatment to shorten IVF cycles and improve reproductive care.

Vvax001, a new HPV16 vaccine, offers a potential alternative to surgery for treating precancerous cervical lesions, with promising trial results.

Myriad Genetics' study shows online tools boost hereditary cancer testing rates, improving patient identification, education, and clinician confidence.

HHS selects 15 more Medicare Part D drugs for price negotiation under the Inflation Reduction Act, aiming to lower costs for millions by 2027.

Find out which articles were the most popular during 2024.

Check out the 5 most popular video interviews of 2024.

The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.

Early HPV vaccination at age 9 boosts completion rates, reduces disparities, and enhances cancer prevention effort, according to a recent study from Nemours Children's Health.

Prenatal exposure to antiseizure medications like valproate and topiramate raises risks of ASD, ADHD, and ID in children; lamotrigine shows no increased risk.

Weak handgrip strength may predict diabetes risk in postmenopausal women, highlighting the importance of muscle strength in diabetes prevention.

Study shows sildenafil cream 3.6% improves sexual arousal in diverse women with FSAD, offering hope for millions seeking effective treatment.

The USPSTF has issued a draft recommendation on cervical cancer screening, find out what physicians need to know.

HPV vaccination in Brazil led to significant reductions in genital warts and cervical precancer hospitalizations, especially among those under 20 years of age.

Panama’s switch to the 9-valent HPV vaccine promises greater protection and reduced cancer rates, preventing thousands of HPV-related cases and deaths.

Iterum Therapeutics has announced the FDA has approved ORLYNVAH (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections (uUTIs)

The New Drug Application (NDA) acceptance is supported by positive data from 3 clinical trials (OASIS 1, 2, and 3).

Matthew Nudy, MD, discusses his team's findings on hormone therapy and cardiovascular effects at the 2024 Annual Meeting of the Menopause Society.

Stephanie Faubion, MD, MBA, medical director of the Menopause Society, shares details from her presentation on hormone therapy at the 2024 Annual Meeting of The Menopause Society.

PH80 nasal spray shows promise in reducing menopausal hot flashes, offering an effective and safe non-hormonal treatment option.

A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.

Wendie Berg, MD, PhD, explains new breast density reporting standards, cancer risks, and the importance of supplemental imaging for dense breast tissue.